27 results
8-K
EX-10.2
DAWN
Day One Biopharmaceuticals, Inc.
30 Jul 24
Day One Announces Oversubscribed $175.0 Million Private Placement
7:04am
and oversee any registration or matters pursuant to this Section 2(f), including participation in any meetings or discussions with the SEC regarding
PRE 14A
dzzhbm8qo5s
18 Apr 23
Preliminary proxy
4:05pm
S-3
EX-1.2
sy2tnxp7j8u
1 Jun 22
Shelf registration
4:06pm
DEF 14A
z74jb
28 Apr 22
Definitive proxy
4:44pm
10-K
ppexyljy
7 Mar 22
Annual report
7:36am
8-K
EX-99.1
dlgxoc2o u4h9og
8 Nov 21
Day One Reports Third Quarter 2021 Financial Results and Corporate Progress
4:51pm
10-Q
ksb9i484
10 Aug 21
Quarterly report
5:26pm